IRIS
CAPECCHI, PIER LEOPOLDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.709
EU - Europa 7.848
AS - Asia 1.496
AF - Africa 50
SA - Sud America 25
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 18.150
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.676
GB - Regno Unito 2.348
IE - Irlanda 1.308
CN - Cina 945
IT - Italia 879
SE - Svezia 781
UA - Ucraina 680
RU - Federazione Russa 545
DE - Germania 533
FR - Francia 391
SG - Singapore 268
FI - Finlandia 215
VN - Vietnam 136
IN - India 48
ES - Italia 45
CI - Costa d'Avorio 42
BE - Belgio 35
TR - Turchia 29
CA - Canada 26
CZ - Repubblica Ceca 21
TH - Thailandia 19
NL - Olanda 17
AU - Australia 12
BR - Brasile 12
IR - Iran 10
GR - Grecia 9
EU - Europa 7
IL - Israele 7
PL - Polonia 6
PE - Perù 5
HK - Hong Kong 4
HR - Croazia 4
JP - Giappone 4
SK - Slovacchia (Repubblica Slovacca) 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
CL - Cile 3
EG - Egitto 3
KG - Kirghizistan 3
MA - Marocco 3
MK - Macedonia 3
MX - Messico 3
PK - Pakistan 3
AM - Armenia 2
AR - Argentina 2
AT - Austria 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BY - Bielorussia 2
DK - Danimarca 2
IM - Isola di Man 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
RO - Romania 2
RS - Serbia 2
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
FK - Isole Falkland (Malvinas) 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HU - Ungheria 1
ID - Indonesia 1
JM - Giamaica 1
JO - Giordania 1
LK - Sri Lanka 1
LT - Lituania 1
NG - Nigeria 1
NP - Nepal 1
PT - Portogallo 1
SA - Arabia Saudita 1
SM - San Marino 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 18.150
Salva come PNG Salva come JPEG
Città #
Southend 2.190
Fairfield 1.433
Dublin 1.283
Ashburn 755
Chandler 691
Woodbridge 673
Jacksonville 548
Wilmington 535
Houston 527
Seattle 505
Cambridge 463
Siena 378
Ann Arbor 363
Menlo Park 358
Princeton 242
Beijing 223
Nanjing 201
Singapore 172
Dong Ket 135
Dearborn 108
Helsinki 107
Boardman 105
San Diego 93
San Mateo 88
New York 86
Nanchang 73
Moscow 59
Florence 54
Shanghai 54
Shenyang 51
Abidjan 42
Málaga 39
Brussels 35
Düsseldorf 34
Hebei 31
Tianjin 30
Changsha 27
Munich 27
Kunming 26
Izmir 25
London 25
Lancaster 24
Jiaxing 23
Jinan 23
Norwalk 23
Falls Church 21
San Francisco 21
Guangzhou 20
Toronto 20
Hefei 18
Fremont 15
Lappeenranta 15
Rome 15
Washington 15
Los Angeles 14
Venezia 14
Brno 13
Milan 13
Pune 13
Zhengzhou 13
Chicago 12
Dallas 12
Caserta 11
Mestre 11
Ningbo 11
Redwood City 11
Changchun 10
Hangzhou 10
Lanzhou 9
Paris 8
Pisa 8
Taizhou 8
Tappahannock 8
Columbus 7
Fuzhou 7
Hounslow 7
Olomouc 7
Phoenix 7
Sacramento 7
Aulla 6
Canberra 6
Delhi 6
Frankfurt am Main 6
Hyderabad 6
Kilburn 6
São Paulo 6
Auburn Hills 5
Lima 5
Ottawa 5
Petah Tikva 5
Rufina 5
Turin 5
Zanjan 5
Amsterdam 4
Bari 4
Bratislava 4
Campi Bisenzio 4
Grosseto 4
Livorno 4
Modena 4
Totale 13.503
Salva come PNG Salva come JPEG
Nome #
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes 286
Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts 252
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 249
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 237
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system 232
Proton pump inhibitors and serum magnesium levels in patients with Torsades de Pointes 232
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 223
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. 219
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 212
Antiarrhythmic potential of anti-cytokine therapy in rheumatoid arthritis: Tocilizumab reduces QTc interval by controlling systemic inflammation. 211
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 209
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 205
Torsades de Pointes in patients with polymyalgia rheumatica 201
Antirheumatic agents in covid-19: is IL-6 the right target? 198
Spotlight on sirukumab for the treatment of rheumatoid arthritis: The evidence to date 193
Peripheral biomarkers' panel for severe COVID-19 patients 192
Adenosine receptors expression in cardiac fibroblasts of patients with left ventricular dysfunction due to valvular disease 186
Polyneuropathy with demyelinating changes in Churg–Strauss syndrome: an unusual association 186
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis 182
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 182
Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6–Mediated Changes in Connexin Expression 180
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 176
Levels of circulating CXCR4-positive cells are decreased and negatively correlated with risk factors in cardiac transplant recipients 175
Pleuroparenchymal fibroelastosis (PPFE) associated with giant cell arteritis: A coincidence or a novel phenotype? 173
Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs 171
Statins and the joint: multiple targets for a global protection? 170
Isolated atrioventricular block of unknown origin in the adult and autoimmunity: Diagnostic and therapeutic considerations exemplified by 3 anti-Ro/SSA-associated cases 164
Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls 161
Connective tissue diseases and cardiac rhythm disorders: an overview 160
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 155
Risk factors for hospital readmission of elderly patients 155
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 154
The role of P2X7 receptors in tissue fibrosis: a brief review 153
Autoimmune and inflammatory K+ channelopathies in cardiac arrhythmias: Clinical evidence and molecular mechanisms 152
Cyclosporin and tacrolimus increase plasma levels of adenosine in kidney transplanted patients 151
Isolated atrioventricular block of unknown origin in adults and anti-Ro/SSA antibodies: Clinical evidence, putative mechanisms, and therapeutic implications 150
Allopurinol prevents ischaemia-dependent haemorheological changes 150
Early and delayed increase in plasma homocysteine levels in heart transplanted patients. 149
Simvastatin inhibits T cell activation by selectively impairing the function of RAS superfamily GTPases 148
Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. 147
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation 146
Heart failure and chronic kidney disease in a registry of internal medicine wards 146
Pharmacokinetics and pharmacodynamics of neutrophil-associated ciprofloxacin in humans 145
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients. 145
Ultrasound measurement of rectus femoris muscle thickness as a quick screening test for sarcopenia assessment 145
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010 143
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 141
The "Invulnerability" of the Adult Conduction System to Anti-Ro/SSA Antibodies? A Matter of Calcium Channel Expression on the Cardiomyocyte 141
Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias 141
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. 140
Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis 140
Using peripheral blood mononuclear cells to determine proteome profiles in human cardiac failure 139
Inflammatory cytokines, life-threatening arrhythmias and premature mortality in chronic inflammatory arthritis: Time to focus on 139
Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad 138
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 138
Development and preliminary validation of a diagnostic score for identifying patients affected with adult-onset autoinflammatory disorders 138
One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies 135
The effects of age and hyperhomocysteinemia on the redox forms of plasma thiols 134
Autoimmune Calcium Channelopathies and Cardiac Electrical Abnormalities 134
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 133
Acute effects of glibenclamide on reactive hyperaemia in the lower limbs in humans. 132
Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment. 132
Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome 130
Homocysteine and Raynaud’s phenomenon: a review 130
Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer. 129
Anti-Ro/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses 129
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 127
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 127
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes 127
null 126
Serial KL-6 measurements in COVID-19 patients 125
Familial Mediterranean fever diagnosed in an elderly patient 124
Cardiac arrest risk during acute infections: systemic inflammation directly prolongs QTc interval via cytokine-mediated effects on potassium channel expression 124
Human rheumatoid synoviocytes express functional P2X7 receptors 123
Proton pump inhibitors directly block hERG-potassium channel and independently increase the risk of QTc prolongation in a large cohort of US Veterans 123
null 122
null 122
Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts 121
Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies 121
Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk 120
null 120
Statins as a new therapeutic perspective in myocarditis and postmyocarditis dilated cardiomyopathy 119
Pathogenesis of the novel autoimmune-associated long-QT syndrome 119
Comment on: Letter to the Editor from Clockaerts and Bierma-Zeinstra 116
Potassium Channel Block and Novel Autoimmune-Associated Long QT Syndrome 116
Emerging arrhythmic risk of autoimmune and inflammatory cardiac channelopathies 116
Adenosine A2(A) receptor gene polymorphism (1976C > T) affects coronary flow reserve response during vasodilator stress testing in patients with non ischemic-dilated cardiomyopathy 115
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, cross-over study in patients with chronic arthritis 115
Surveillance for severe acute respiratory infections among hospitalized subjects from 2015/2016 to 2019/2020 seasons in Tuscany, Italy 115
Priming for Pandemic Influenza: Antigen-sparing MF59™-adjuvanted A/H5N1 Vaccine Induces Immunological Memory and Shows Cross-Reactive Potential in Adults Including the Elderly 114
Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation 114
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A oral echocardiographic study 113
Photopheresis immunomodulation after heart transplantation. 110
Arrhythmogenic effects of anti-Ro/SSA antibodies on theadult heart: more than expected? 110
Long QT Syndrome: An Emerging Role for Inflammation and Immunity 109
Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology) 109
Inhibition of microsomal glucose-6-phosphate transport in human neutrophils results in apoptosis: a potential explanation for neutrophil dysfunction in glycogen storage disease type 1b 107
Simvastatin reduces MMP-3 level in interleukin 1b-stimulated human chondrocyte culture 107
null 105
Using Peripheral Blood Mononuclear Cells to determine proteome profiles in human end-stage chronic heart disease 105
Totale 15.050
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.320
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.320
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.463 0 0 0 0 230 356 423 476 313 331 124 210
2020/20213.042 134 257 92 352 169 340 201 365 321 284 254 273
2021/20222.192 159 283 133 169 159 74 130 96 138 195 220 436
2022/20232.560 161 250 366 373 204 501 74 187 265 55 68 56
2023/20242.219 93 48 176 111 110 613 686 54 26 62 61 179
2024/20251.004 85 216 392 266 45 0 0 0 0 0 0 0
Totale 18.488